Michael Lund

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial

Lone B Enebo, Kasper K. Berthelsen, Martin Kankam et al. · The Lancet · 2021 · 286 citations

Phase 1B, Multiple Doses, Medicine +3

Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial

Thomas A. Wadden, Jena Shaw Tronieri, Danny Sugimoto et al. · Obesity · 2020 · 183 citations · Full text

High‐intensity interval training improves insulin sensitivity in older individuals

Ditte Søgaard, Michael Lund, Cathrine Munk Scheuer et al. · Acta Physiologica · 2017 · 95 citations

Adipose tissue mitochondrial respiration and lipolysis before and after a weight loss by diet and <scp>RYGB</scp>

Merethe Hansen, Michael Lund, Emilie Gregers et al. · Obesity · 2015 · 53 citations · Full text

Hepatic mitochondrial oxidative phosphorylation is normal in obese patients with and without type 2 diabetes

Michael Lund, M. Kristensen, Merethe Hansen et al. · The Journal of Physiology · 2016 · 36 citations · Full text